(Q43187349)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

15 November 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Aurora kinase inhibitor AZD1152 negatively affects the growth and survival of HTLV-1-infected T lymphocytes in vitro (English)

1 reference

Human T-lymphotropic virus 1

15 November 2017

main subject

0 references

2

Yuetsu Tanaka

1 reference

15 November 2017

Mariko Tomita

1

1 reference

15 November 2017

Naoki Mori

series ordinal

3

1 reference

15 November 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

International Journal of Cancer

15 November 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

15 November 2017

volume

127

1 reference

15 November 2017

issue

7

1 reference

15 November 2017

page(s)

1584-1594

1 reference

Overexpression of Aurora A by loss of CHFR gene expression increases the growth and survival of HTLV-1-infected T cells through enhanced NF-kappaB activity

15 November 2017

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/IJC.24257

The aurora B kinase inhibitor AZD1152 sensitizes cancer cells to fractionated irradiation and induces mitotic catastrophe

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

The selective Aurora B kinase inhibitor AZD1152 is a potential new treatment for multiple myeloma.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

Aurora-A - a guardian of poles

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

Aurora-kinase inhibitors as anticancer agents

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

Aurora kinases: new targets for cancer therapy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

p53: puzzle and paradigm

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

Regulation of mitotic chromosome cohesion by Haspin and Aurora B.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

G1 tetraploidy checkpoint and the suppression of tumorigenesis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

Discovery and development of aurora kinase inhibitors as anticancer agents

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

The cellular geography of aurora kinases

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

PHA-680632, a novel Aurora kinase inhibitor with potent antitumoral activity.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

The Kaposi's sarcoma-associated herpesvirus K-bZIP protein represses transforming growth factor beta signaling through interaction with CREB-binding protein

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

Analysis of Aurora B kinase in non-Hodgkin lymphoma

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

Human T-cell leukemia virus type 1 Tax interacts with Chk1 and attenuates DNA-damage induced G2 arrest mediated by Chk1.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

Dynamic localization and functional implications of Aurora-C kinase during male mouse meiosis.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

Aurora kinases link chromosome segregation and cell division to cancer susceptibility

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

Heterogeneity of antigen molecules recognized by anti-tax1 monoclonal antibody Lt-4 in cell lines bearing human T cell leukemia virus type I and related retroviruses

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinase

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

Aurora kinases as anticancer drug targets

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

AZD1152 rapidly and negatively affects the growth and survival of human acute myeloid leukemia cells in vitro and in vivo

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1002/IJC.25178

Identifiers

DOI

10.1002/IJC.25178

1 reference

15 November 2017

1 reference